Literature DB >> 15290868

Uptake of the carborane derivative of cholesteryl ester by glioma cancer cells is mediated through LDL receptors.

Guangliang Pan1, Svein Oie, D Robert Lu.   

Abstract

PURPOSE: This study was to elucidate the mechanism of cellular uptake of cholesteryl 1,12-dicarba-closo-dodecaboranel-carboxylate (BCH), a new anti-cancer carborane derivative of cholesteryl ester, by glioma cancer cells.
METHODS: BCH (solubilized with liposomal formulation) was incubated with SF-763 and SF-767 glioma cell lines in the presence of different amounts of monoclonal anti-LDL receptor antibody for cellular uptake studies. Various amounts of lipoprotein deficient serum (LPDS) were also used during the uptake. The effect of calcium ion and low temperature on BCH uptake were investigated. In addition, the transfer of BCH from liposomes to low-density lipoprotein (LDL) particles was determined through gradient ultracentrifugation.
RESULTS: BCH uptake by these glioma cells was significantly inhibited by the monoclonal antibody. The uptake by both cell lines was reversely correlated with the amount of LPDS. The presence of calcium ion promoted the BCH uptake, whereas the low temperature decreased the BCH uptake. After 16 h incubation, about 46% of BCH was transferred from liposomes to LDL particles.
CONCLUSIONS: These results strongly suggested that the cellular uptake of BCH (in liposomal formulation) by SF-763 and SF-767 glioma cell lines is mediated through LDL receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15290868     DOI: 10.1023/b:pham.0000033014.04820.a7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  17 in total

1.  Synthesis of cholesterol-carborane conjugate for targeted drug delivery.

Authors:  Bingqing Ji; Gina Peacock; D Robert Lu
Journal:  Bioorg Med Chem Lett       Date:  2002-09-02       Impact factor: 2.823

2.  Human glioblastoma cell lines: levels of low-density lipoprotein receptor and low-density lipoprotein receptor-related protein.

Authors:  L Maletínská; E A Blakely; K A Bjornstad; D F Deen; L J Knoff; T M Forte
Journal:  Cancer Res       Date:  2000-04-15       Impact factor: 12.701

3.  Brain drug delivery of small molecules using immunoliposomes.

Authors:  J Huwyler; D Wu; W M Pardridge
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

4.  Folate receptor type beta is a neutrophilic lineage marker and is differentially expressed in myeloid leukemia.

Authors:  J F Ross; H Wang; F G Behm; P Mathew; M Wu; R Booth; M Ratnam
Journal:  Cancer       Date:  1999-01-15       Impact factor: 6.860

Review 5.  Folate-mediated targeting of therapeutic and imaging agents to cancers.

Authors:  J A Reddy; P S Low
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1998       Impact factor: 4.889

Review 6.  Immunotherapy of folate receptor-expressing tumors: review of recent advances and future prospects.

Authors:  Yingjuan Lu; Philip S Low
Journal:  J Control Release       Date:  2003-08-28       Impact factor: 9.776

Review 7.  Molecular targets in cancer therapy.

Authors:  Danielle M Gale
Journal:  Semin Oncol Nurs       Date:  2003-08       Impact factor: 2.315

8.  Monoclonal antibodies to the low density lipoprotein receptor as probes for study of receptor-mediated endocytosis and the genetics of familial hypercholesterolemia.

Authors:  U Beisiegel; W J Schneider; J L Goldstein; R G Anderson; M S Brown
Journal:  J Biol Chem       Date:  1981-11-25       Impact factor: 5.157

9.  In vitro uptake of a new cholesteryl carborane ester compound by human glioma cell lines.

Authors:  Gina Peacock; Richard Sidwell; Guangliang Pan; Svein Øle; D Robert Lu
Journal:  J Pharm Sci       Date:  2004-01       Impact factor: 3.534

10.  A new function for the LDL receptor: transcytosis of LDL across the blood-brain barrier.

Authors:  B Dehouck; L Fenart; M P Dehouck; A Pierce; G Torpier; R Cecchelli
Journal:  J Cell Biol       Date:  1997-08-25       Impact factor: 10.539

View more
  1 in total

1.  Photothrombosis of corneal neovascularization by photodynamic therapy utilizing verteporfin and diode laser.

Authors:  Aziza Ahmed Hassan; Dina Foad Ghoneim; Amr Abdelraheem El-Dib; Salwa Abdelkawi Ahmed; Ahmed Medhat Abdel-Salam
Journal:  J Lasers Med Sci       Date:  2013
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.